Showing results (81-90 of 90) with videos related to
Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Transplant Immunology|April 14, 2009
B7-H4 transfection prolongs beta-cell graft survivalChun-Lei Yuan, Jun-Fa Xu, Jing Tong, et al.Advances in Therapy|May 19, 2026
Efficacy and Safety of Firsekibart in Patients with Acute Gout Unsuitable for Standard Therapy: 48-Week Results from an Open-Label Extension of a Randomized Phase 3 TrialZaihua Zhu, Yu Xue, Tianshu Chu, et al.Innovation (Cambridge (Mass.))|August 15, 2025
Firsekibart versus compound betamethasone in acute gout patients unsuitable for standard therapy: A randomized phase 3 trialYu Xue, Tianshu Chu, Jiankang Hu, et al.Clinical and Vaccine Immunology : CVI|March 13, 2015
Immunogenicity and efficacy of flagellin-envelope fusion dengue vaccines in mice and monkeysGe Liu, Langzhou Song, David W C Beasley, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|February 28, 2019
Alpha2B-Adrenergic Receptor Overexpression in the Brain Potentiate Air Pollution-induced Behavior and Blood Pressure ChangesXiaoquan Rao, Laureano D Asico, Panos Zanos, et al.Rheumatology (Oxford, England)|January 4, 2026
Anti-mitochondrial M2 antibody links to cardiac involvement and immune-mediated inflammatory myopathy-like pathology in myositisYiyun Pang, Lixi Zhang, Chen Yao, et al.Molecular Pharmacology|April 24, 2014
Discovery and characterization of a G protein-biased agonist that inhibits β-arrestin recruitment to the D2 dopamine receptorR Benjamin Free, Lani S Chun, Amy E Moritz, et al.BMC Medicine|December 8, 2025
Efficacy and safety of Janus kinase 1/2 inhibitor KL130008 in active rheumatoid arthritis: a randomized, double-blind, placebo-controlled phase II trialYue Cheng, Honghu Tang, Yufeng Qing, et al.Annals of the Rheumatic Diseases|May 24, 2025
CD4+ tissue-resident memory Th17 cells are a major source of IL-17A in Spondyloarthritis synovial tissueFeng Liu, Hui Shi, Jason D Turner, et al.Journal of Hepatology|July 30, 2023
Metabolic biomarkers significantly enhance the prediction of HBV-related ACLF occurrence and outcomesYan Zhang, Wenting Tan, Xianbo Wang, et al.Pageof 9